A new multifunctionalized material against multi-drug resistant bacteria and abnormal osteoclast activity

Area of Science:

• Biomaterials Science
• Nanotechnology
• Orthopedics

Background:

• Age-related musculoskeletal disorders necessitate advanced biomaterials for bone regeneration and resorption inhibition.
• Increasing antibiotic resistance in bacteria is a major cause of implant failure, demanding novel antimicrobial strategies.

Purpose of the Study:

• To develop multifunctional composite crystals integrating hydroxyapatite, zoledronate, and silver nanoparticles (AgNPs).
• To evaluate the combined therapeutic potential of zoledronate and AgNPs for bone health and infection control.

Main Methods:

• Incorporation of zoledronate (a bisphosphonate) into hydroxyapatite up to 8 wt%.
• Functionalization with poly(ethylenimine)-stabilized AgNPs, confirmed by zeta potential changes.
• In vitro assessment of osteoblast activity, osteoclastogenesis, and antimicrobial efficacy against multi-drug resistant bacteria.

Main Results:

• The composite crystals demonstrated improved osteoblast differentiation and activity.
• Significant inhibition of osteoclastogenesis and osteoclast differentiation was observed.
• Marked hindrance of growth for both Gram-positive and Gram-negative multi-drug resistant bacteria.

Conclusions:

• The developed multifunctional materials possess dual antiresorptive and antimicrobial properties.
• These materials show promise for treating bone loss and preventing bone-associated infections.
• Potential applications include managing age-related musculoskeletal disorders and improving orthopedic implant longevity.